Position in EYPT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$68,741,215
+$3,664,788 QoQ
Shares Held
4,807,078
-4.8% QoQ
Ownership
5.58%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#6
of 188 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EYPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $9,179,114,031 across 176 Biotechnology names. EYPT ranks #25 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,771,839 | $1,728,352,485 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,347,253 | $1,662,680,977 | |
| 3 | ASND |
Ascendis Pharma A/S
|
1,862,503 | $496,766,798 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
2,040,250 | $491,639,040 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,488,394 | $278,746,426 | |
| 6 | INSM |
INSMED Inc
|
2,273,222 | $242,370,927 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
752,044 | $237,713,585 | |
| 8 | ARGX |
Argenx SE
|
224,930 | $208,683,303 |
All Filings in EYPT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $68,741,215 | 4,807,078 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $65,076,427 | 5,048,598 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $90,928,235 | 4,976,915 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $59,407,627 | 4,171,884 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $40,473,566 | 4,301,123 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $22,492,246 | 4,149,861 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $30,824,872 | 4,137,567 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $32,056,261 | 4,012,048 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $31,751,946 | 3,649,649 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $70,055,528 | 3,389,237 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $107,245,443 | 4,640,651 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $33,178,033 | 4,152,445 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $44,061,870 | 5,064,583 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $16,987,730 | 5,778,140 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $20,210,781 | 5,774,509 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $44,374,126 | 5,609,877 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $42,893,489 | 5,450,253 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $64,635,909 | 5,319,828 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $60,553,298 | 4,947,165 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $33,076,590 | 3,174,337 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $25,142,089 | 2,796,673 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $29,344,589 | 2,888,247 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $9,303,771 | 1,413,947 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $2,151,500 | 4,137,500 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $3,144,500 | 4,137,500 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $4,220,250 | 4,137,500 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||